1
|
Lewis RK, Bleiler DS, Smith RC, Allard DJ. Residential Homes with Extremely High Indoor Radon Concentrations in Southern Lehigh County, Pennsylvania. Health Phys 2022; 123:360-364. [PMID: 35951339 DOI: 10.1097/hp.0000000000001604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
ABSTRACT A housing development of 87 new homes on approximately 300 acres of former farm land was found to have 19 homes with basement radon-222 ( 222 Rn) concentrations greater than 37,000 Bq m -3 , with the highest recorded result to date being 648,000 +/- 1,031 Bq m -3 , based upon the diffusion barrier charcoal canister result. The US Environmental Protection Agency (EPA) Action Level for 222 Rn is 148 Bq m -3 . This single-family housing development is in the southeast corner of Lehigh County, Pennsylvania, about 58 km northwest of Philadelphia, in a geologic unit known as the Epler Formation. Radon testing in homes in this development began in the fall of 2014 and is now complete. Initial testing consisted of charcoal canisters mailed to homeowners. Subsequent testing in newly built homes consisted of testing prior to occupancy. This testing was quite extensive, with continuous radon monitors, passive radon monitors, and grab sampling for radon gas and progeny in the basement and on the first floor of each home as well as gamma surveys in the basement, on the first and second floors, and outside of each home. All but one of the new houses in this development had passive radon resistant features installed during the construction phase. In all cases, fans were added to the passive systems to make them active systems, which were needed to control these extremely high radon levels. Additional radon mitigation work such as adding additional suction points was also needed in several homes to reduce levels to below EPA guidelines. The unique geology and high 226 Ra soil concentrations in this specific area are the causes of these extremely high radon levels. Radon measurement data both inside these homes and in the outdoor ambient air, as well as 238 U and 222 Ra rock and soil concentrations, are presented.
Collapse
Affiliation(s)
- R K Lewis
- PA Department of Environmental Protection Bureau of Radiation Protection, P.O. Box 8469, Harrisburg, PA 17105
| | - D S Bleiler
- PA Department of Environmental Protection Bureau of Radiation Protection, P.O. Box 8469, Harrisburg, PA 17105
| | - R C Smith
- Retired; PA Department of Conservation and Natural Resources PA Geological Survey, Retired Middletown, PA
| | - D J Allard
- PA Department of Environmental Protection Bureau of Radiation Protection, P.O. Box 8469, Harrisburg, PA 17105
| |
Collapse
|
2
|
Borek DM, Smith RC, Gruber CN, Gruber BL. Long-term persistence in patients with osteoporosis receiving denosumab in routine practice: 36-month non-interventional, observational study. Osteoporos Int 2019; 30:1455-1464. [PMID: 31011760 DOI: 10.1007/s00198-019-04963-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Accepted: 03/31/2019] [Indexed: 10/27/2022]
Abstract
UNLABELLED Persistence rates over 36 months with denosumab in patients diagnosed with osteoporosis in a real-world setting were examined, along with baseline patient characteristics predictive of persistence. This study represents the longest observational period with denosumab persistence and shows higher persistence rates when compared to bisphosphonates. INTRODUCTION The study objective was to describe long-term persistence with denosumab among patients treated for osteoporosis in a real-world setting. We also sought to examine patient characteristics predictive of persistence. Lastly, this study attempted to place the results in context by conducting a literature review of published persistence data for denosumab. METHODS This retrospective, non-interventional study analyzed 1158 patients from a specialty community private practice to assess patient persistence with denosumab in routine care. Persistence was defined as receiving seven denosumab injections, using an 8-week permissible gap, over 36 months. Non-persistent patients were further investigated retrospectively to identify reasons for discontinuation, when available. RESULTS Demographic analysis showed a population of 1158 patients with mean age 68.4 years old and baseline T-score - 2.7; nearly half of which experienced a prior osteoporosis-related fracture. In a Kaplan-Meier survival analysis, 36-month persistence overall was 50.7%. Net persistence, as defined by receiving seven injections in the allowable time frame, was 64.2% of the cohort. In a multivariate analysis, prior vertebral fractures and recent osteoporosis therapy were associated with higher persistence; age greater than 75 years was associated with non-persistence. Reasons for discontinuation were available in 91.6% of non-persistent patients and categorized to include the ten most common explanations. CONCLUSION This study to our knowledge represents the longest continuous observational period providing data on denosumab persistence in a real-world setting. The total persistence noted is quite robust when compared to bisphosphonates and is within the upper range of prior published studies of denosumab with shorter observation periods.
Collapse
Affiliation(s)
- D M Borek
- City College of New York, New York, NY, USA
| | - R C Smith
- State University of New York at Binghamton, Binghamton, NY, USA
| | - C N Gruber
- Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - B L Gruber
- Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Long Island Regional Arthritis and Osteoporosis Care, PC, Babylon, NY, USA.
| |
Collapse
|
3
|
Smith RC, Duncanson J, Ruckley CV, Webber RG, Allan NC, Dawes J, Bolton AE, Hunter WM, Pepper DS, Cash JD. β-Thromboglobulin and Deep Vein Thrombosis. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1646694] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryThe measurement of plasma β-thromboglobulin as a potential diagnostic test for venous thrombosis has been investigated in 16 normal volunteers, 24 patients presenting with deep vein thrombosis (DVT) or pulmonary embolism and 46 patients screened by 125 I fibrinogen test (IFT) for post-operative DVT. The normal mean was 33 ng/ml (range 15-117 ng/ml). Of the 24 patients with clinical thrombotic disease 22 presented with DVT confirmed by phlebogram or IFT and 2 presented with embolism confirmed by lung scan. At the time of first presentation 12 out of 24 had βTG values greater than 70 ng/ml. All except 3 of this group of 24 patients had values of greater than 70 ng/ml at some stage during a subsequent week of daily sampling. DVT was detected in 13 out of 46 screened post-operative patients. There was a rise in βTG observed within 24 hr of the IFT becoming positive but the mean rise did not reach significance at the 5% level.An association between DVT and high βTG values has been confirmed. However, its clinical value cannot yet be fully elucidated until factors, probably related to blood sampling and clearance, are further investigated.
Collapse
Affiliation(s)
- R C Smith
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - Jeanette Duncanson
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - C V Ruckley
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - R G Webber
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - N C Allan
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - Joan Dawes
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - A E Bolton
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - W M Hunter
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - D S Pepper
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| | - J D Cash
- The Department of Clinical Surgery and the General Surgery Unit, Western General Hospital; the Medical Research Council Radio-Immunoassay Laboratory, Forrest Road and the Regional Blood Transfusion Service, Edinburgh, Great Britain
| |
Collapse
|
4
|
Cohen-Hallaleh RB, Smith HG, Smith RC, Stamp GF, Al-Muderis O, Thway K, Miah A, Khabra K, Judson I, Jones R, Benson C, Hayes AJ. Radiation induced angiosarcoma of the breast: outcomes from a retrospective case series. Clin Sarcoma Res 2017; 7:15. [PMID: 28794852 PMCID: PMC5547463 DOI: 10.1186/s13569-017-0081-7] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2017] [Accepted: 07/29/2017] [Indexed: 01/04/2023] Open
Abstract
Background Radiation induced angiosarcoma (RIAS) of the breast is a rare and aggressive complication of radiotherapy. Due to the rarity of this disease, much of the evidence for its management is based on case reports or small retrospective series. We sought to describe the management and outcomes of RIAS in a large single-institution series. Methods All patients diagnosed with RIAS between January 2000 and January 2014 were identified from an institutional database. Results A total of 49 patients were identified. Median age at diagnosis was 72 years (range 51–93). Median time from completion of radiotherapy to diagnosis of RIAS was 7.5 years. Median tumour size at presentation was 5.0 cm (1.5–19.0). The majority of patients presented with localised disease (47, 95.9%). Of these, 35 (74.5%) were suitable for surgery and underwent surgery with curative intent. Twelve patients presented with localised irresectable disease. Of these, 7 received systemic chemotherapy, with a sufficient response to facilitate surgery in 3 patients. Following potentially curative surgery, 2-year local recurrence-free was 55.2%. Survival was significantly prolonged in patients presenting with resectable disease (2-year overall survival 71.1% vs 33.3%, p < 0.001). Tumour size >5 cm was prognostic of distant metastases-free survival and overall survival. Conclusion RIAS are rare, aggressive soft-tissue lesions with limited treatment options and high-rates of both local and systemic relapse.
Collapse
Affiliation(s)
- R B Cohen-Hallaleh
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - H G Smith
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - R C Smith
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - G F Stamp
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - O Al-Muderis
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - K Thway
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - A Miah
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - K Khabra
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - I Judson
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - R Jones
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - C Benson
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| | - A J Hayes
- The Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust, London, UK
| |
Collapse
|
5
|
Affiliation(s)
- R. C. Smith
- Battelle-Pacific Northwest Laboratory Richland, Washington 99352
| | - L. G. Faust
- Battelle-Pacific Northwest Laboratory Richland, Washington 99352
| | | |
Collapse
|
6
|
Schlichtemeier SM, Pang TC, Williams NE, Gill AJ, Smith RC, Samra JS, Lam VWT, Hollands M, Richardson AJ, Pleass HC, Nozawa S, Albania M, Hugh TJ. A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience. Eur J Surg Oncol 2016; 42:1576-83. [PMID: 27378158 DOI: 10.1016/j.ejso.2016.05.032] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2016] [Revised: 05/22/2016] [Accepted: 05/26/2016] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Hepatocellular cancer (HCC) is a leading cause of mortality worldwide. Liver resection or transplantation offer the best chance of long-term survival. The aim of this study was to perform a survival and prognostic factor analysis on patients who underwent resection of HCC at two major tertiary referral hospitals, and to investigate a pre-operative prediction model for microvascular invasion (MVI). METHODS Clinico-pathological and survival data were collected from all patients who underwent liver resection for HCC at two tertiary referral centres (Royal North Shore/North Shore Private Hospitals and Westmead Hospital) from 1998 to 2012. An overall and disease-free survival analysis was performed and a predictive model for MVI identified. RESULTS The total number of patients in this series was 125 and the 5-year overall and disease-free survival rates were 56% and 37%, respectively. MVI was the only factor to be independently associated with a poor prognosis on both overall and disease-free survival. Age ≥64 years, a serum alpha-fetoprotein (AFP) ≥400 ng/ml (×40 above normal) and tumor size ≥50 mm were independently associated with MVI. An MVI prediction model using these three pre-operative factors provides a good assessment of the risk of MVI. CONCLUSION MVI in the resected specimen of patients with HCC is associated with a poor prognosis. A preoperative MVI prediction model offers a useful way to identify patients at risk of relapse. However, more precise predictive models using molecular and genetic variables are needed to improve selection of patients most suitable for radical surgical treatment.
Collapse
Affiliation(s)
- S M Schlichtemeier
- Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Australia
| | - T C Pang
- Department of Upper Gastrointestinal Surgery, Westmead Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - N E Williams
- Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Australia
| | - A J Gill
- Department of Anatomical Pathology, Royal North Shore Hospital and Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - R C Smith
- Discipline of Surgery, University of Sydney, Australia
| | - J S Samra
- Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - V W T Lam
- Department of Upper Gastrointestinal Surgery, Westmead Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - M Hollands
- Department of Upper Gastrointestinal Surgery, Westmead Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - A J Richardson
- Department of Upper Gastrointestinal Surgery, Westmead Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - H C Pleass
- Department of Upper Gastrointestinal Surgery, Westmead Hospital, Australia; Discipline of Surgery, University of Sydney, Australia
| | - S Nozawa
- Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Australia
| | - M Albania
- Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Australia
| | - T J Hugh
- Upper Gastrointestinal Surgical Unit, Royal North Shore Hospital and North Shore Private Hospital, Australia; Discipline of Surgery, University of Sydney, Australia.
| |
Collapse
|
7
|
Kessler R, Marriner J, Childress M, Covarrubias R, D’Andrea CB, Finley DA, Fischer J, Foley RJ, Goldstein D, Gupta RR, Kuehn K, Marcha M, Nichol RC, Papadopoulos A, Sako M, Scolnic D, Smith M, Sullivan M, Wester W, Yuan F, Abbott T, Abdalla FB, Allam S, Benoit-Lévy A, Bernstein GM, Bertin E, Brooks D, Rosell AC, Kind MC, Castander FJ, Crocce M, Costa LND, Desai S, Diehl HT, Eifler TF, Neto AF, Flaugher B, Frieman J, Gerdes DW, Gruen D, Gruendl RA, Honscheid K, James DJ, Kuropatkin N, Li TS, Maia MAG, Marshall JL, Martini P, Miller CJ, Miquel R, Nord B, Ogando R, Plazas AA, Reil K, Romer AK, Roodman A, Sanchez E, Sevilla-Noarbe I, Smith RC, Soares-Santos M, Sobreira F, Tarle G, Thaler J, Thomas RC, Tucker D, Walker AR. THE DIFFERENCE IMAGING PIPELINE FOR THE TRANSIENT SEARCH IN THE DARK ENERGY SURVEY. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-6256/150/6/172] [Citation(s) in RCA: 106] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
8
|
Flaugher B, Diehl HT, Honscheid K, Abbott TMC, Alvarez O, Angstadt R, Annis JT, Antonik M, Ballester O, Beaufore L, Bernstein GM, Bernstein RA, Bigelow B, Bonati M, Boprie D, Brooks D, Buckley-Geer EJ, Campa J, Cardiel-Sas L, Castander FJ, Castilla J, Cease H, Cela-Ruiz JM, Chappa S, Chi E, Cooper C, da Costa LN, Dede E, Derylo G, DePoy DL, de Vicente J, Doel P, Drlica-Wagner A, Eiting J, Elliott AE, Emes J, Estrada J, Fausti Neto A, Finley DA, Flores R, Frieman J, Gerdes D, Gladders MD, Gregory B, Gutierrez GR, Hao J, Holland SE, Holm S, Huffman D, Jackson C, James DJ, Jonas M, Karcher A, Karliner I, Kent S, Kessler R, Kozlovsky M, Kron RG, Kubik D, Kuehn K, Kuhlmann S, Kuk K, Lahav O, Lathrop A, Lee J, Levi ME, Lewis P, Li TS, Mandrichenko I, Marshall JL, Martinez G, Merritt KW, Miquel R, Muñoz F, Neilsen EH, Nichol RC, Nord B, Ogando R, Olsen J, Palaio N, Patton K, Peoples J, Plazas AA, Rauch J, Reil K, Rheault JP, Roe NA, Rogers H, Roodman A, Sanchez E, Scarpine V, Schindler RH, Schmidt R, Schmitt R, Schubnell M, Schultz K, Schurter P, Scott L, Serrano S, Shaw TM, Smith RC, Soares-Santos M, Stefanik A, Stuermer W, Suchyta E, Sypniewski A, Tarle G, Thaler J, Tighe R, Tran C, Tucker D, Walker AR, Wang G, Watson M, Weaverdyck C, Wester W, Woods R, Yanny B. THE DARK ENERGY CAMERA. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-6256/150/5/150] [Citation(s) in RCA: 580] [Impact Index Per Article: 64.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
9
|
Goldstein DA, D’Andrea CB, Fischer JA, Foley RJ, Gupta RR, Kessler R, Kim AG, Nichol RC, Nugent PE, Papadopoulos A, Sako M, Smith M, Sullivan M, Thomas RC, Wester W, Wolf RC, Abdalla FB, Banerji M, Benoit-Lévy A, Bertin E, Brooks D, Rosell AC, Castander FJ, Costa LND, Covarrubias R, DePoy DL, Desai S, Diehl HT, Doel P, Eifler TF, Neto AF, Finley DA, Flaugher B, Fosalba P, Frieman J, Gerdes D, Gruen D, Gruendl RA, James D, Kuehn K, Kuropatkin N, Lahav O, Li TS, Maia MAG, Makler M, March M, Marshall JL, Martini P, Merritt KW, Miquel R, Nord B, Ogando R, Plazas AA, Romer AK, Roodman A, Sanchez E, Scarpine V, Schubnell M, Sevilla-Noarbe I, Smith RC, Soares-Santos M, Sobreira F, Suchyta E, Swanson MEC, Tarle G, Thaler J, Walker AR. AUTOMATED TRANSIENT IDENTIFICATION IN THE DARK ENERGY SURVEY. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-6256/150/3/82] [Citation(s) in RCA: 94] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
10
|
Drlica-Wagner A, Albert A, Bechtol K, Wood M, Strigari L, Sánchez-Conde M, Baldini L, Essig R, Cohen-Tanugi J, Anderson B, Bellazzini R, Bloom ED, Caputo R, Cecchi C, Charles E, Chiang J, Angelis AD, Funk S, Fusco P, Gargano F, Giglietto N, Giordano F, Guiriec S, Gustafsson M, Kuss M, Loparco F, Lubrano P, Mirabal N, Mizuno T, Morselli A, Ohsugi T, Orlando E, Persic M, Rainò S, Sehgal N, Spada F, Suson DJ, Zaharijas G, Zimmer S, Abbott T, Allam S, Balbinot E, Bauer AH, Benoit-Lévy A, Bernstein RA, Bernstein GM, Bertin E, Brooks D, Buckley-Geer E, Burke DL, Rosell AC, Castander FJ, Covarrubias R, D’Andrea CB, Costa LND, DePoy DL, Desai S, Diehl HT, Cunha CE, Eifler TF, Estrada J, Evrard AE, Neto AF, Fernandez E, Finley DA, Flaugher B, Frieman J, Gaztanaga E, Gerdes D, Gruen D, Gruendl RA, Gutierrez G, Honscheid K, Jain B, James D, Jeltema T, Kent S, Kron R, Kuehn K, Kuropatkin N, Lahav O, Li TS, Luque E, Maia MAG, Makler M, March M, Marshall J, Martini P, Merritt KW, Miller C, Miquel R, Mohr J, Neilsen E, Nord B, Ogando R, Peoples J, Petravick D, Pieres A, Plazas AA, Queiroz A, Romer AK, Roodman A, Rykoff ES, Sako M, Sanchez E, Santiago B, Scarpine V, Schubnell M, Sevilla I, Smith RC, Soares-Santos M, Sobreira F, Suchyta E, Swanson MEC, Tarle G, Thaler J, Thomas D, Tucker D, Walker AR, Wechsler RH, Wester W, Williams P, Yanny B, Zuntz J. SEARCH FOR GAMMA-RAY EMISSION FROM DES DWARF SPHEROIDAL GALAXY CANDIDATES WITH
FERMI
-LAT DATA. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/2041-8205/809/1/l4] [Citation(s) in RCA: 119] [Impact Index Per Article: 13.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
11
|
Chang C, Vikram V, Jain B, Bacon D, Amara A, Becker MR, Bernstein G, Bonnett C, Bridle S, Brout D, Busha M, Frieman J, Gaztanaga E, Hartley W, Jarvis M, Kacprzak T, Kovács A, Lahav O, Lin H, Melchior P, Peiris H, Rozo E, Rykoff E, Sánchez C, Sheldon E, Troxel MA, Wechsler R, Zuntz J, Abbott T, Abdalla FB, Allam S, Annis J, Bauer AH, Benoit-Lévy A, Brooks D, Buckley-Geer E, Burke DL, Capozzi D, Carnero Rosell A, Carrasco Kind M, Castander FJ, Crocce M, D'Andrea CB, Desai S, Diehl HT, Dietrich JP, Doel P, Eifler TF, Evrard AE, Fausti Neto A, Flaugher B, Fosalba P, Gruen D, Gruendl RA, Gutierrez G, Honscheid K, James D, Kent S, Kuehn K, Kuropatkin N, Maia MAG, March M, Martini P, Merritt KW, Miller CJ, Miquel R, Neilsen E, Nichol RC, Ogando R, Plazas AA, Romer AK, Roodman A, Sako M, Sanchez E, Sevilla I, Smith RC, Soares-Santos M, Sobreira F, Suchyta E, Tarle G, Thaler J, Thomas D, Tucker D, Walker AR. Wide-Field Lensing Mass Maps from Dark Energy Survey Science Verification Data. Phys Rev Lett 2015; 115:051301. [PMID: 26274409 DOI: 10.1103/physrevlett.115.051301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/07/2015] [Indexed: 06/04/2023]
Abstract
We present a mass map reconstructed from weak gravitational lensing shear measurements over 139 deg2 from the Dark Energy Survey science verification data. The mass map probes both luminous and dark matter, thus providing a tool for studying cosmology. We find good agreement between the mass map and the distribution of massive galaxy clusters identified using a red-sequence cluster finder. Potential candidates for superclusters and voids are identified using these maps. We measure the cross-correlation between the mass map and a magnitude-limited foreground galaxy sample and find a detection at the 6.8σ level with 20 arc min smoothing. These measurements are consistent with simulated galaxy catalogs based on N-body simulations from a cold dark matter model with a cosmological constant. This suggests low systematics uncertainties in the map. We summarize our key findings in this Letter; the detailed methodology and tests for systematics are presented in a companion paper.
Collapse
Affiliation(s)
- C Chang
- Department of Physics, ETH Zurich, Wolfgang-Pauli-Strasse 16, CH-8093 Zurich, Switzerland
| | - V Vikram
- Argonne National Laboratory, 9700 South Cass Avenue, Lemont, Illinois 60439, USA
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - B Jain
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - D Bacon
- Institute of Cosmology and Gravitation, University of Portsmouth, Portsmouth PO1 3FX, United Kingdom
| | - A Amara
- Department of Physics, ETH Zurich, Wolfgang-Pauli-Strasse 16, CH-8093 Zurich, Switzerland
| | - M R Becker
- Department of Physics, Stanford University, 382 Via Pueblo Mall, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford University, P. O. Box 2450, Stanford, California 94305, USA
| | - G Bernstein
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - C Bonnett
- Institut de Física d'Altes Energies, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain
| | - S Bridle
- Jodrell Bank Center for Astrophysics, School of Physics and Astronomy, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom
| | - D Brout
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - M Busha
- Department of Physics, Stanford University, 382 Via Pueblo Mall, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford University, P. O. Box 2450, Stanford, California 94305, USA
| | - J Frieman
- Kavli Institute for Cosmological Physics, University of Chicago, Chicago, Illinois 60637, USA
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - E Gaztanaga
- Institut de Ciències de l'Espai, IEEC-CSIC, Campus UAB, Facultat de Ciències, Torre C5 par-2, 08193 Bellaterra, Barcelona, Spain
| | - W Hartley
- Department of Physics, ETH Zurich, Wolfgang-Pauli-Strasse 16, CH-8093 Zurich, Switzerland
| | - M Jarvis
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - T Kacprzak
- Department of Physics, ETH Zurich, Wolfgang-Pauli-Strasse 16, CH-8093 Zurich, Switzerland
| | - A Kovács
- Institut de Física d'Altes Energies, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain
| | - O Lahav
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - H Lin
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - P Melchior
- Center for Cosmology and Astro-Particle Physics, The Ohio State University, Columbus, Ohio 43210, USA
- Department of Physics, The Ohio State University, Columbus, Ohio 43210, USA
| | - H Peiris
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - E Rozo
- Department of Physics, University of Arizona, 1118 East Fourth Street, Tucson, Arizona 85721, USA
| | - E Rykoff
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford University, P. O. Box 2450, Stanford, California 94305, USA
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - C Sánchez
- Institut de Física d'Altes Energies, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain
| | - E Sheldon
- Brookhaven National Laboratory, Building 510, Upton, New York 11973, USA
| | - M A Troxel
- Jodrell Bank Center for Astrophysics, School of Physics and Astronomy, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom
| | - R Wechsler
- Department of Physics, Stanford University, 382 Via Pueblo Mall, Stanford, California 94305, USA
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford University, P. O. Box 2450, Stanford, California 94305, USA
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - J Zuntz
- Jodrell Bank Center for Astrophysics, School of Physics and Astronomy, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom
| | - T Abbott
- Cerro Tololo Inter-American Observatory, National Optical Astronomy Observatory, Casilla 603, La Serena, Chile
| | - F B Abdalla
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - S Allam
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - J Annis
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - A H Bauer
- Institut de Ciències de l'Espai, IEEC-CSIC, Campus UAB, Facultat de Ciències, Torre C5 par-2, 08193 Bellaterra, Barcelona, Spain
| | - A Benoit-Lévy
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - D Brooks
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - E Buckley-Geer
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - D L Burke
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford University, P. O. Box 2450, Stanford, California 94305, USA
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - D Capozzi
- Institute of Cosmology and Gravitation, University of Portsmouth, Portsmouth PO1 3FX, United Kingdom
| | - A Carnero Rosell
- Laboratório Interinstitucional de e-Astronomia-LIneA, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
- Observatório Nacional, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
| | - M Carrasco Kind
- Department of Physics, University of Illinois, 1110 West Green Street, Urbana, Illinois 61801, USA
- National Center for Supercomputing Applications, 1205 West Clark Street, Urbana, Illinois 61801, USA
| | - F J Castander
- Institut de Ciències de l'Espai, IEEC-CSIC, Campus UAB, Facultat de Ciències, Torre C5 par-2, 08193 Bellaterra, Barcelona, Spain
| | - M Crocce
- Institut de Ciències de l'Espai, IEEC-CSIC, Campus UAB, Facultat de Ciències, Torre C5 par-2, 08193 Bellaterra, Barcelona, Spain
| | - C B D'Andrea
- Institute of Cosmology and Gravitation, University of Portsmouth, Portsmouth PO1 3FX, United Kingdom
| | - S Desai
- Department of Physics, Ludwig-Maximilians-Universitaet, Scheinerstrasse 1, 81679 Munich, Germany
| | - H T Diehl
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - J P Dietrich
- Department of Physics, Ludwig-Maximilians-Universitaet, Scheinerstrasse 1, 81679 Munich, Germany
- Excellence Cluster Universe, Boltzmannstrasse 2, 85748 Garching, Germany
| | - P Doel
- Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, United Kingdom
| | - T F Eifler
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California 91109, USA
| | - A E Evrard
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - A Fausti Neto
- Laboratório Interinstitucional de e-Astronomia-LIneA, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
| | - B Flaugher
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - P Fosalba
- Institut de Ciències de l'Espai, IEEC-CSIC, Campus UAB, Facultat de Ciències, Torre C5 par-2, 08193 Bellaterra, Barcelona, Spain
| | - D Gruen
- Max Planck Institute for Extraterrestrial Physics, Giessenbachstrasse, 85748 Garching, Germany
- University Observatory Munich, Scheinerstrasse 1, 81679 Munich, Germany
| | - R A Gruendl
- Department of Physics, University of Illinois, 1110 West Green Street, Urbana, Illinois 61801, USA
- National Center for Supercomputing Applications, 1205 West Clark Street, Urbana, Illinois 61801, USA
| | - G Gutierrez
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - K Honscheid
- Department of Physics, University of Illinois, 1110 West Green Street, Urbana, Illinois 61801, USA
- National Center for Supercomputing Applications, 1205 West Clark Street, Urbana, Illinois 61801, USA
| | - D James
- Cerro Tololo Inter-American Observatory, National Optical Astronomy Observatory, Casilla 603, La Serena, Chile
| | - S Kent
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - K Kuehn
- Australian Astronomical Observatory, North Ryde, New South Wales 2113, Australia
| | - N Kuropatkin
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - M A G Maia
- Laboratório Interinstitucional de e-Astronomia-LIneA, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
- Observatório Nacional, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
| | - M March
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - P Martini
- Center for Cosmology and Astro-Particle Physics, The Ohio State University, Columbus, Ohio 43210, USA
- Department of Physics, The Ohio State University, Columbus, Ohio 43210, USA
| | - K W Merritt
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - C J Miller
- Department of Physics, University of Michigan, Ann Arbor, Michigan 48109, USA
- Department of Astronomy, University of Michigan, Ann Arbor, Michigan 48109, USA
| | - R Miquel
- Institut de Física d'Altes Energies, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats, E-08010 Barcelona, Spain
| | - E Neilsen
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - R C Nichol
- Institute of Cosmology and Gravitation, University of Portsmouth, Portsmouth PO1 3FX, United Kingdom
| | - R Ogando
- Laboratório Interinstitucional de e-Astronomia-LIneA, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
- Observatório Nacional, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
| | - A A Plazas
- Brookhaven National Laboratory, Building 510, Upton, New York 11973, USA
- Jet Propulsion Laboratory, California Institute of Technology, 4800 Oak Grove Drive, Pasadena, California 91109, USA
| | - A K Romer
- Department of Physics and Astronomy, Pevensey Building, University of Sussex, Brighton BN1 9QH, United Kingdom
| | - A Roodman
- Kavli Institute for Particle Astrophysics and Cosmology, Stanford University, P. O. Box 2450, Stanford, California 94305, USA
- SLAC National Accelerator Laboratory, Menlo Park, California 94025, USA
| | - M Sako
- Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
| | - E Sanchez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid 28040, Spain
| | - I Sevilla
- Department of Physics, University of Illinois, 1110 West Green Street, Urbana, Illinois 61801, USA
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid 28040, Spain
| | - R C Smith
- Cerro Tololo Inter-American Observatory, National Optical Astronomy Observatory, Casilla 603, La Serena, Chile
| | - M Soares-Santos
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - F Sobreira
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
- Laboratório Interinstitucional de e-Astronomia-LIneA, Rua General Jos´e Cristino 77, Rio de Janeiro, RJ 20921-400, Brazil
| | - E Suchyta
- Center for Cosmology and Astro-Particle Physics, The Ohio State University, Columbus, Ohio 43210, USA
- Department of Physics, The Ohio State University, Columbus, Ohio 43210, USA
| | - G Tarle
- Department of Physics, Ludwig-Maximilians-Universitaet, Scheinerstrasse 1, 81679 Munich, Germany
| | - J Thaler
- Department of Physics, University of Illinois, 1110 West Green Street, Urbana, Illinois 61801, USA
| | - D Thomas
- Institute of Cosmology and Gravitation, University of Portsmouth, Portsmouth PO1 3FX, United Kingdom
- SEPnet, South East Physics Network, Southampton SO17 1BJ, United Kingdom
| | - D Tucker
- Fermi National Accelerator Laboratory, P. O. Box 500, Batavia, Illinois 60510, USA
| | - A R Walker
- Cerro Tololo Inter-American Observatory, National Optical Astronomy Observatory, Casilla 603, La Serena, Chile
| |
Collapse
|
12
|
Simon JD, Drlica-Wagner A, Li TS, Nord B, Geha M, Bechtol K, Balbinot E, Buckley-Geer E, Lin H, Marshall J, Santiago B, Strigari L, Wang M, Wechsler RH, Yanny B, Abbott T, Bauer AH, Bernstein GM, Bertin E, Brooks D, Burke DL, Capozzi D, Rosell AC, Kind MC, D’Andrea CB, Costa LND, DePoy DL, Desai S, Diehl HT, Dodelson S, Cunha CE, Estrada J, Evrard AE, Neto AF, Fernandez E, Finley DA, Flaugher B, Frieman J, Gaztanaga E, Gerdes D, Gruen D, Gruendl RA, Honscheid K, James D, Kent S, Kuehn K, Kuropatkin N, Lahav O, Maia MAG, March M, Martini P, Miller CJ, Miquel R, Ogando R, Romer AK, Roodman A, Rykoff ES, Sako M, Sanchez E, Schubnell M, Sevilla I, Smith RC, Soares-Santos M, Sobreira F, Suchyta E, Swanson MEC, Tarle G, Thaler J, Tucker D, Vikram V, Walker AR, Wester W. STELLAR KINEMATICS AND METALLICITIES IN THE ULTRA-FAINT DWARF GALAXY RETICULUM II. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/808/1/95] [Citation(s) in RCA: 109] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
13
|
Bechtol K, Drlica-Wagner A, Balbinot E, Pieres A, Simon JD, Yanny B, Santiago B, Wechsler RH, Frieman J, Walker AR, Williams P, Rozo E, Rykoff ES, Queiroz A, Luque E, Benoit-Lévy A, Tucker D, Sevilla I, Gruendl RA, Costa LND, Neto AF, Maia MAG, Abbott T, Allam S, Armstrong R, Bauer AH, Bernstein GM, Bernstein RA, Bertin E, Brooks D, Buckley-Geer E, Burke DL, Rosell AC, Castander FJ, Covarrubias R, D’Andrea CB, DePoy DL, Desai S, Diehl HT, Eifler TF, Estrada J, Evrard AE, Fernandez E, Finley DA, Flaugher B, Gaztanaga E, Gerdes D, Girardi L, Gladders M, Gruen D, Gutierrez G, Hao J, Honscheid K, Jain B, James D, Kent S, Kron R, Kuehn K, Kuropatkin N, Lahav O, Li TS, Lin H, Makler M, March M, Marshall J, Martini P, Merritt KW, Miller C, Miquel R, Mohr J, Neilsen E, Nichol R, Nord B, Ogando R, Peoples J, Petravick D, Plazas AA, Romer AK, Roodman A, Sako M, Sanchez E, Scarpine V, Schubnell M, Smith RC, Soares-Santos M, Sobreira F, Suchyta E, Swanson MEC, Tarle G, Thaler J, Thomas D, Wester W, Zuntz J. EIGHT NEW MILKY WAY COMPANIONS DISCOVERED IN FIRST-YEAR DARK ENERGY SURVEY DATA. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/807/1/50] [Citation(s) in RCA: 401] [Impact Index Per Article: 44.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
14
|
Smith RC, Misra CH, Allen R, Gordon J. Dosage and blood levels of neuroleptics in tardive dyskinesia. Mod Probl Pharmacopsychiatry 2015; 21:87-96. [PMID: 6140636 DOI: 10.1159/000408486] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
15
|
Guidotti A, Auta J, Davis JM, Dong E, Gavin DP, Grayson DR, Sharma RP, Smith RC, Tueting P, Zhubi A. Toward the identification of peripheral epigenetic biomarkers of schizophrenia. J Neurogenet 2014; 28:41-52. [PMID: 24702539 DOI: 10.3109/01677063.2014.892485] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Schizophrenia (SZ) is a heritable, nonmendelian, neurodevelopmental disorder in which epigenetic dysregulation of the brain genome plays a fundamental role in mediating the clinical manifestations and course of the disease. The authors recently reported that two enzymes that belong to the dynamic DNA methylation/demethylation network-DNMT (DNA methyltransferase) and TET (ten-eleven translocase; 5-hydroxycytosine translocator)-are abnormally increased in corticolimbic structures of SZ postmortem brain, suggesting a causal relationship between clinical manifestations of SZ and changes in DNA methylation and in the expression of SZ candidate genes (e.g., brain-derived neurotrophic factor [BDNF], glucocorticoid receptor [GCR], glutamic acid decarboxylase 67 [GAD67], reelin). Because the clinical manifestations of SZ typically begin with a prodrome followed by a first episode in adolescence with subsequent deterioration, it is obvious that the natural history of this disease cannot be studied only in postmortem brain. Hence, the focus is currently shifting towards the feasibility of studying epigenetic molecular signatures of SZ in blood cells. Initial studies show a significant enrichment of epigenetic changes in lymphocytes in gene networks directly relevant to psychiatric disorders. Furthermore, the expression of DNA-methylating/demethylating enzymes and SZ candidate genes such as BDNF and GCR are altered in the same direction in both brain and blood lymphocytes. The coincidence of these changes in lymphocytes and brain supports the hypothesis that common environmental or genetic risk factors are operative in altering the epigenetic components involved in orchestrating transcription of specific genes in brain and peripheral tissues. The identification of DNA methylation signatures for SZ in peripheral blood cells of subjects with genetic and clinical high risk would clearly have potential for the diagnosis of SZ early in its course and would be invaluable for initiating early intervention and individualized treatment plans.
Collapse
Affiliation(s)
- A Guidotti
- Psychiatric Institute, Department of Psychiatry, School of Medicine, University of Illinois , Chicago, Chicago, Illinois , USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Piccioni A, Gaetani E, Palladino M, Gatto I, Smith RC, Neri V, Marcantoni M, Giarretta I, Silver M, Straino S, Capogrossi M, Landolfi R, Pola R. Sonic hedgehog gene therapy increases the ability of the dystrophic skeletal muscle to regenerate after injury. Gene Ther 2014; 21:413-21. [PMID: 24572787 DOI: 10.1038/gt.2014.13] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2013] [Revised: 01/04/2014] [Accepted: 01/15/2014] [Indexed: 11/09/2022]
Abstract
The Hedgehog (Hh) pathway is a crucial regulator of muscle development during embryogenesis. We have previously demonstrated that Sonic hedgehog (Shh) regulates postnatal myogenesis in the adult skeletal muscle both directly, by acting on muscle satellite cells, and indirectly, by promoting the production of growth factors from interstitial fibroblasts. Here, we show that in mdx mice, the murine equivalent of Duchenne muscular dystrophy in humans, progression of the dystrophic pathology corresponds to progressive inhibition of the Hh signaling pathway in the skeletal muscle. We also show that the upregulation of the Hh pathway in response to injury and during regeneration is significantly impaired in mdx muscle. Shh treatment increases the proliferative potential of satellite cells isolated from the muscles of mdx mice. This treatment also increases the production of proregenerative factors, such as insulin-like growth factor-1 and vascular endothelial growth factor, from fibroblasts isolated from the muscle of mdx mice. In vivo, overexpression of the Hh pathway using a plasmid encoding the human Shh gene promotes successful regeneration after injury in terms of increased number of proliferating myogenic cells and newly formed myofibers, as well as enhanced vascularization and decreased fibrosis.
Collapse
Affiliation(s)
- A Piccioni
- 1] Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy [2] Division of Cardiovascular Research, Steward St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
| | - E Gaetani
- Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy
| | - M Palladino
- 1] Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy [2] Division of Cardiovascular Research, Steward St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
| | - I Gatto
- Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy
| | - R C Smith
- Division of Cardiovascular Research, Steward St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
| | - V Neri
- 1] Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy [2] Division of Cardiovascular Research, Steward St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
| | - M Marcantoni
- Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy
| | - I Giarretta
- Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy
| | - M Silver
- Division of Cardiovascular Research, Steward St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
| | - S Straino
- 1] Laboratory of Vascular Pathology, IDI IRCCS Research Institute, Rome, Italy [2] Explora Biotech, srl, Rome, Italy
| | - M Capogrossi
- Laboratory of Vascular Pathology, IDI IRCCS Research Institute, Rome, Italy
| | - R Landolfi
- Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy
| | - R Pola
- 1] Department of Medicine, A. Gemelli University Hospital, Catholic University School of Medicine, Rome, Italy [2] Division of Cardiovascular Research, Steward St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA, USA
| |
Collapse
|
17
|
Becker EA, Forney KA, Foley DG, Smith RC, Moore TJ, Barlow J. Predicting seasonal density patterns of California cetaceans based on habitat models. ENDANGER SPECIES RES 2014. [DOI: 10.3354/esr00548] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
18
|
Xue A, Chang JW, Chung L, Samra J, Hugh T, Gill A, Butturini G, Baxter RC, Smith RC. Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer 2013; 107:1883-91. [PMID: 23169340 PMCID: PMC3504954 DOI: 10.1038/bjc.2012.458] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
BACKGROUND Pancreaticoduodenectomy remains a major undertaking. A preoperative blood test, which could confidently predict the benefits of surgery would improve the selection of pancreatic cancer patients for surgery. This study aimed to identify protein biomarkers prognostic for long-term survival and to validate them with clinico-pathological information. METHODS Serum from 40 preoperative patients was used to train for predictive biomarkers using surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI), and the results were verified on 21 independent samples. Two predictive proteins were identified by tryptic peptide mass fingerprinting and sequencing, and validated on serum from another 57 patients by enzyme-linked immunosorbent assay (ELISA). The influence of these proteins on growth and invasion of two cancer cell lines was tested in-vitro. RESULTS The SELDI panel of m/z 3700, 8222 and 11 522 peaks predicted <12 months' survival (ROC AUC: 0.79, 0.64-0.90; P<0.039). When CA19-9 was added, the ROC AUC increased to 0.95 (0.84-0.99; P<0.0001). The six subjects in the verification group who died within 12 months were correctly classified. The m/z 8222 and 11 522 proteins were identified as Serum ApoC-II and SAA-1, respectively. In the validation samples, ELISA results confirmed that ApoC-II was predictive of survival (Kaplan-Meier P<0.009), but not SAA-I. ApoC-II, CA19-9 and major-vessel involvement independently predicted survival. ApoC-II and SAA-1 increased cell growth and invasion of both cancer cell lines. CONCLUSION Serum ApoC-II, CA19-9 and major-vessel invasion independently predict survival and improves selection of patients for pancreaticoduodenectomy.
Collapse
Affiliation(s)
- A Xue
- Department of Gastrointestinal Surgery, University of Sydney, Kolling Institute of Medical Research, St Leonards NSW 2065, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Wang YH, Trucksis M, McElwee JJ, Wong PH, Maciolek C, Thompson CD, Prueksaritanont T, Garrett GC, Declercq R, Vets E, Willson KJ, Smith RC, Klappenbach JA, Opiteck GJ, Tsou JA, Gibson C, Laethem T, Panorchan P, Iwamoto M, Shaw PM, Wagner JA, Harrelson JC. UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study. Clin Pharmacol Ther 2012; 92:96-102. [PMID: 22669291 PMCID: PMC3380185 DOI: 10.1038/clpt.2012.20] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
MK-7246, an antagonist of the chemoattractant receptor on T helper type 2 (Th2) cells, is being developed for the treatment of respiratory diseases. In a first-in-human study, we investigated whether genetic polymorphisms contributed to the marked intersubject variability in the pharmacokinetics of MK-7246 and its glucuronide metabolite M3. Results from in vitro enzyme kinetic studies suggested that UGT2B17 is probably the major enzyme responsible for MK-7246 metabolism in both the liver and the intestine. As compared with those with the UGT2B17*1/*1 wild-type genotype, UGT2B17*2/*2 carriers, who possess no UGT2B17 protein, had 25- and 82-fold greater mean dose-normalized values of area under the plasma concentration–time curve (AUC) and peak concentration of MK-7246, respectively, and a 24-fold lower M3-to-MK-7246 AUC ratio. The apparent half-life of MK-7246 was not as variable between these two genotypes. Therefore, the highly variable pharmacokinetics of MK-7246 is attributable primarily to the impact of UGT2B17 genetic polymorphisms and extensive first-pass metabolism of MK-7246.
Collapse
Affiliation(s)
- Y-H Wang
- Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, West Point, Pennsylvania, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Rest A, Prieto JL, Walborn NR, Smith N, Bianco FB, Chornock R, Welch DL, Howell DA, Huber ME, Foley RJ, Fong W, Sinnott B, Bond HE, Smith RC, Toledo I, Minniti D, Mandel K. Rest et al. reply. Nature 2012. [DOI: 10.1038/nature11167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
21
|
Rest A, Prieto JL, Walborn NR, Smith N, Bianco FB, Chornock R, Welch DL, Howell DA, Huber ME, Foley RJ, Fong W, Sinnott B, Bond HE, Smith RC, Toledo I, Minniti D, Mandel K. Light echoes reveal an unexpectedly cool η Carinae during its nineteenth-century Great Eruption. Nature 2012; 482:375-8. [PMID: 22337057 DOI: 10.1038/nature10775] [Citation(s) in RCA: 62] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2011] [Accepted: 12/08/2011] [Indexed: 11/09/2022]
Abstract
η Carinae is one of the most massive binary stars in the Milky Way. It became the second-brightest star in our sky during its mid-nineteenth-century 'Great Eruption', but then faded from view (with only naked-eye estimates of brightness). Its eruption is unique in that it exceeded the Eddington luminosity limit for ten years. Because it is only 2.3 kiloparsecs away, spatially resolved studies of the nebula have constrained the ejected mass and velocity, indicating that during its nineteenth-century eruption, η Car ejected more than ten solar masses in an event that released ten per cent of the energy of a typical core-collapse supernova, without destroying the star. Here we report observations of light echoes of η Carinae from the 1838-1858 Great Eruption. Spectra of these light echoes show only absorption lines, which are blueshifted by -210 km s(-1), in good agreement with predicted expansion speeds. The light-echo spectra correlate best with those of G2-to-G5 supergiants, which have effective temperatures of around 5,000 kelvin. In contrast to the class of extragalactic outbursts assumed to be analogues of the Great Eruption of η Carinae, the effective temperature of its outburst is significantly lower than that allowed by standard opaque wind models. This indicates that other physical mechanisms such as an energetic blast wave may have triggered and influenced the eruption.
Collapse
Affiliation(s)
- A Rest
- Space Telescope Science Institute, 3700 San Martin Drive, Baltimore, Maryland 21218, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Abstract
Environmental and genetic conditions can cause proteins to misfold or to accumulate abnormally due to impaired clearance. The chaperones which include heat shock proteins, aid survival by preventing protein mis-folding and the formation of cytotoxic protein aggregates. An increasing number of studies point to important roles for molecular chaperones in the biology of neurodegenerative diseases. Heat shock proteins can suppress neurotoxicity in animal models of Parkinson's and polyglutamine diseases, suggesting potential new therapeutic approaches in neurodegenerative disorders associated with abnormal protein folding and toxicity. Recent findings suggest that heat shock proteins can also be neuroprotective in Alzheimer's disease, but this area of research remains largely unexplored. This paper will review the literature related to the role of heat shock proteins in Alzheimer's disease.
Collapse
Affiliation(s)
- R C Smith
- New England OncoTherapeutics Inc., Cambridge, MA 02142, USA.
| | | | | | | |
Collapse
|
23
|
Filip LD, Smith RC, Carey JD, Silva SRP. Electron transfer from a carbon nanotube into vacuum under high electric fields. J Phys Condens Matter 2009; 21:195302. [PMID: 21825476 DOI: 10.1088/0953-8984/21/19/195302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
The transfer of an electron from a carbon nanotube (CNT) tip into vacuum under a high electric field is considered beyond the usual one-dimensional semi-classical approach. A model of the potential energy outside the CNT cap is proposed in order to show the importance of the intrinsic CNT parameters such as radius, length and vacuum barrier height. This model also takes into account set-up parameters such as the shape of the anode and the anode-to-cathode distance, which are generically portable to any modelling study of electron emission from a tip emitter. Results obtained within our model compare well to experimental data. Moreover, in contrast to the usual one-dimensional Wentzel-Kramers-Brillouin description, our model retains the ability to explain non-standard features of the process of electron field emission from CNTs that arise as a result of the quantum behaviour of electrons on the surface of the CNT.
Collapse
Affiliation(s)
- L D Filip
- Nano Electronics Centre, Advanced Technology Institute, University of Surrey, Guildford, Surrey GU2 7XH, UK
| | | | | | | |
Collapse
|
24
|
Smith RC, Oerther DB. Respirometric evaluation of side-stream treatment of reject water as a source of nitrifying bacteria for main-stream activated sludge bioreactors. Water Sci Technol 2009; 60:2677-2684. [PMID: 19923774 PMCID: PMC6844249 DOI: 10.2166/wst.2009.621] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
A laboratory-scale bioreactor study was conducted to characterize differences in nitrification function in main-stream reactors due to bioaugmentation from side-stream reactors treating reject water. The objective was to evaluate how configuration of a suspended growth side-stream bioreactor impacts nitrification function in the main-stream bioreactor. A bioaugmentation effect was not observed in main-stream reactors operated at warm temperatures. Complete oxidation of ammonia to nitrate was observed in the bioaugmented and control main-stream reactors although nitrite accumulation was observed in each case. Furthermore, respirometry did not reveal superior kinetics in bioaugmented reactors operated at warm temperatures. At cold temperatures bioaugmentation may have stabilized ammonia oxidation in main-stream reactor B2 bioaugmented from a PFR side-stream. Complete ammonia oxidation was observed for most of cold period of operation in the main-stream bioreactor B2. Furthermore, respirometry revealed a higher rate of ammonia oxidation and more stable nitrite oxidation compared with the control bioreactor.
Collapse
Affiliation(s)
- R C Smith
- Malcolm Pirnie, Inc., 1900 Polaris Parkway, Columbus, OH 43240, USA.
| | | |
Collapse
|
25
|
Stammerjohn SE, Martinson DG, Smith RC, Yuan X, Rind D. Trends in Antarctic annual sea ice retreat and advance and their relation to El Niño–Southern Oscillation and Southern Annular Mode variability. ACTA ACUST UNITED AC 2008. [DOI: 10.1029/2007jc004269] [Citation(s) in RCA: 517] [Impact Index Per Article: 32.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
26
|
Smith RC, Saikaly PE, Zhang K, Thomatos S, Oerther DB. Ecological engineering of bioaugmentation from side-stream nitrification. Water Sci Technol 2008; 57:1927-1933. [PMID: 18587180 DOI: 10.2166/wst.2008.628] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Wastewater treatment relies on careful integration of environmental engineering with microbial ecology. This would seem to be particularly the case when attempting to enhance survivability of organisms introduced from outside the main-stream reactor, i.e. bioaugmentation. Molecular biology tools were utilised in this study to assist in understanding the mechanisms of successful bioaugmentation. Molecular fingerprinting showed that side-stream reactor configuration strongly influenced ammonia-oxidising bacteria (AOB) community structure. In both lab-scale and full-scale systems, AOB communities in the side-stream and main-stream were very similar. The experimental systems revealed that a PFR side-stream produced greater diversity of AOB than a CSTR side-stream in a PFR main-stream system, whereas the full-scale side-stream resulted in essentially an AOB monoculture. Phylogenetic analysis revealed less diversity than molecular fingerprinting perhaps due to biases in the cloning/transformation procedure.
Collapse
Affiliation(s)
- R C Smith
- Malcolm Pirnie Inc., 1900 Polaris Parkway, Columbus, OH 43240, USA.
| | | | | | | | | |
Collapse
|
27
|
Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia. Pharmacogenomics J 2007; 8:228-36. [PMID: 17726453 DOI: 10.1038/sj.tpj.6500474] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Schizophrenic patients who are treated with antipsychotics, especially second generation antipsychotics, such as clozapine and olanzapine, manifest an increase in cholesterol and triglycerides as well as other changes associated with diabetes or the metabolic syndrome. Previous studies have shown that polymorphisms in several genes that regulate lipid metabolism can influence the levels of these lipids and response to drug treatment. We have investigated in an exploratory study whether polymorphisms in the apolipoprotein C-III (ApoC3), apolipoprotein A-V gene (ApoA5) and lipoprotein lipase genes influence differential lipid response to treatment with three second generation antipsychotics-olanzapine, clozapine and risperidone-or treatment with a first generation antipsychotic. A total of 189 patients with schizophrenia or schizoaffective disorder who were being treated with a single antipsychotic were studied in a cross-sectional study design in which fasting serum cholesterol and triglycerides and selected single-nucleotide polymorphosms (SNPs) in the three lipid metabolism genes were assessed. The treatment with antipsychotic monotherapy makes drug haplotype ascertainment less complex. Our analyses showed several nominally significant drug x gene and drug x haplotype interactions. The rarer C allele or the ApoA5_1131 (T/C) SNP was associated with higher cholesterol levels in patients treated with first generation antipsychotics and lower cholesterol levels in patients treated with olanzapine or clozapine. The rarer C allele of the ApoA5_SW19 (G/C) SNP was associated with higher cholesterol in risperidone-treated patients. An ApoA5 CG haplotype was associated with decreased cholesterol in olanzapine- or clozapine-treated patients and higher cholesterol in patients treated with first generation antipsychotics. The presence of the rarer T allele of the ApoC3_1100 (C/T) SNP or the presence of the ApoC3 TG haplotype was associated with decreased triglyceride levels in patients treated with olanzapine or clozapine and a nonsignificant trend for increased triglycerides in patients treated with first generation antipsychotics. The presence of the ApoC3 CC haplotype was associated with increased triglycerides in patients treated with olanzapine or clozapine. The overall magnitude of the effects was not large. These results provide a potential initial step toward a pharmacogenetic approach to selection of antipsychotic treatment which may help minimize the side effect of increases in serum lipids.
Collapse
Affiliation(s)
- R C Smith
- Department of Psychiatry, New York University Medical School and Manhattan Psychiatric Center, New York, NY 11557-0316, USA.
| | | | | | | | | |
Collapse
|
28
|
Mitchell PJ, Hanson JC, Quets-Nguyen AT, Bergeron M, Smith RC. A quantitative method for analysis of in vitro neurite outgrowth. J Neurosci Methods 2007; 164:350-62. [PMID: 17570533 DOI: 10.1016/j.jneumeth.2007.04.021] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2006] [Revised: 04/26/2007] [Accepted: 04/26/2007] [Indexed: 11/28/2022]
Abstract
The adult mammalian CNS is extremely limited in its ability to regenerate axons following injury. Glial scar, neuroinflammatory processes and molecules released from myelin impair axonal regrowth and contribute to the lack of neural regeneration. An in vitro assay that quantitates neurite outgrowth from cultured neurons as a model of neuronal regenerative potential is described. Specifically, the neurite outgrowth from primary neurons (rat cerebellar granule neurons; CGNs) and a neuronal cell line (NG108-15) were quantitatively measured after optimization of culture conditions. After cultures were fixed and immunostained to label neurons and nuclei, microscope images were captured and an image analysis algorithm was developed using Image-Pro Plus software to allow quantitative analysis. The algorithm allowed the determination of total neurite length, number of neurons, and number of neurons without neurites. The algorithm also allows for end-user control of thresholds for staining intensity and cell/nuclei size. This assay represents a useful tool for quantification of neurite outgrowth from a variety of neuronal sources with applications that include: (1) assessment of neurite outgrowth potential; (2) identification of molecules that can block or stimulate neurite outgrowth in conventional culture media; and (3) identification of agents that can overcome neurite outgrowth inhibition by inhibitory substrates.
Collapse
Affiliation(s)
- P J Mitchell
- Biotechnology Discovery Research, Lilly Research Labs, DC 0344, Lilly Corporate Center, Indianapolis, IN 46285, United States
| | | | | | | | | |
Collapse
|
29
|
Baxter RC, Smith RC, Scarlett CJ, Xue A, Butturini G, Scarpa A. HP07 PROTEOMIC IDENTIFICATION OF SERUM MARKERS OF PANCREATIC ADENOCARCINOMA USING SELDI-TOF MS. ANZ J Surg 2007. [DOI: 10.1111/j.1445-2197.2007.04122_7.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
30
|
Smith RC, Pender S. HP06 PANCREATIC ABSCESS: RESULTS OF A SURGEON?S PROTOCOL. ANZ J Surg 2007. [DOI: 10.1111/j.1445-2197.2007.04122_6.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Maldjian C, Patel TY, Klein RM, Smith RC. Efficacy of MRI in classifying proximal focal femoral deficiency. Skeletal Radiol 2007; 36:215-20. [PMID: 17051388 DOI: 10.1007/s00256-006-0218-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2006] [Revised: 08/29/2006] [Accepted: 09/01/2006] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To evaluate the efficacy of MRI in classifying PFFD and to compare MRI to radiographic classification of PFFD. DESIGN Radiographic and MRI classification of the cases was performed utilizing the Amstutz classification system. PATIENTS Retrospective evaluation of radiographs and MRI exams in nine hips of eight patients with proximal focal femoral deficiency was performed by two radiologists. RESULTS The cases were classified by radiographs as Amstutz 1: n=3, Amstutz 3: n=3, Amstutz 4: n=1 and Amstutz 5: n=2. The classifications based on MRI were Amstutz 1: n=6, Amstutz 2: n=1, Amstutz 3: n=0, Amstutz 4: n=2 and Amstutz 5: n=0. Three hips demonstrated complete agreement. There were six discordant hips. In two of the discordant cases, follow-up radiographs of 6 months or greater intervals were available and helped to confirm MRI findings. Errors in radiographic evaluation consisted of overestimating the degree of deficiency. CONCLUSION MRI is more accurate than radiographic evaluation for the classification of PFFD, particularly early on, prior to the ossification of cartilaginous components in the femurs. Since radiographic evaluation tends to overestimate the degree of deficiency, MRI is a more definitive modality for evaluation of PFFD.
Collapse
Affiliation(s)
- C Maldjian
- New York Medical College, 95 Grasslands Road, Valhalla, NY 10595, USA
| | | | | | | |
Collapse
|
32
|
Smith RC, Walter MF, Hice RH, O'Brochta DA, Atkinson PW. Testis-specific expression of the beta2 tubulin promoter of Aedes aegypti and its application as a genetic sex-separation marker. Insect Mol Biol 2007; 16:61-71. [PMID: 17257209 DOI: 10.1111/j.1365-2583.2006.00701.x] [Citation(s) in RCA: 67] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Sex-specific expression of transgenes in pest insects enables novel genetic control strategies, based either on genetic sexing or the spread of transgenes through the germ-line, to be developed and then tested for implementation. We describe the isolation of the beta tubulin genes from the yellow fever mosquito, Aedes aegypti, and the identification of the particular beta2 tubulin gene which has expression confined to the testes. We demonstrate that the beta2 tubulin promoter of Ae. aegypti can direct the expression of a DsRed genetic marker in the testes and show that labelled sperm can be detected in inseminated spermathecae. The applications for this technology in the genetic control of Ae. aegypti are discussed.
Collapse
Affiliation(s)
- R C Smith
- Program in Cell, Molecular, and Developmental Biology, University of California, Riverside, CA 92521, USA
| | | | | | | | | |
Collapse
|
33
|
Abstract
Recent results continue to show the general consensus that ozone-related increases in UV-B radiation can negatively influence many aquatic species and aquatic ecosystems (e.g., lakes, rivers, marshes, oceans). Solar UV radiation penetrates to ecological significant depths in aquatic systems and can affect both marine and freshwater systems from major biomass producers (phytoplankton) to consumers (e.g., zooplankton, fish, etc.) higher in the food web. Many factors influence the depth of penetration of radiation into natural waters including dissolved organic compounds whose concentration and chemical composition are likely to be influenced by future climate and UV radiation variability. There is also considerable evidence that aquatic species utilize many mechanisms for photoprotection against excessive radiation. Often, these protective mechanisms pose conflicting selection pressures on species making UV radiation an additional stressor on the organism. It is at the ecosystem level where assessments of anthropogenic climate change and UV-related effects are interrelated and where much recent research has been directed. Several studies suggest that the influence of UV-B at the ecosystem level may be more pronounced on community and trophic level structure, and hence on subsequent biogeochemical cycles, than on biomass levels per se.
Collapse
Affiliation(s)
- D-P Häder
- Institut für Botanik und Pharmazeutische Biologie, Friedrich-Alexander-Universität, Staudtstr. 5, D-91058 Erlangen, Germany
| | | | | | | |
Collapse
|
34
|
Andrady AL, Aucamp PJ, Bais AF, Ballaré CL, Bjorn LO, Bornman JF, Caldwell MM, Cullen AP, de Gruijl FR, Erickson DJ, Flint SD, Häder DP, Hamid HS, Ilyas M, Kulandaivelu G, Kumar HD, McKenzie RL, Longstreth J, Lucas RM, Noonan FP, Norval M, Paul ND, Smith RC, Soloman KR, Sulzberger B, Takizawa Y, Tang X, Torikai A, van der Leun JC, Wilson SR, Worrest RC, Zepp RG. Environmental effects of ozone depletion: 2006 assessment: interactions of ozone depletion and climate change : Executive summary. Photochem Photobiol Sci 2007; 6:212-7. [PMID: 17344958 DOI: 10.1039/b700050m] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
35
|
Affiliation(s)
- S Gananadha
- Upper GI/HPB Surgical Unit, Royal North Shore Hospital, St Leonards, New South Wales, Australia
| | | |
Collapse
|
36
|
Smith RC, Oerther DB. Microbial community development in a laboratory-scale nitrifying activated sludge system with input from a side-stream bioreactor treating digester supernatant. Water Sci Technol 2006; 54:209-16. [PMID: 16898154 DOI: 10.2166/wst.2006.389] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
Three laboratory-scale activated sludge treatment trains were operated to investigate the effect on biodiversity in plug flow (PFR) main-stream sewage treatment from input of biomass from side-stream reactors treating anaerobic digester supernatant. One train had a completely mixed (CSTR) side-stream reactor, one a PFR side-stream reactor, and the third train was a control that did not receive input from a side-stream reactor. Restriction endonucleases were used to digest polymerase chain reaction-amplified ammonia monooxygenase subunit A (amoA) genes in monthly samples from each reactor. Restriction fragment banding patterns from polyacrylimide gel electrophoresis indicated that the structure of the ammonia oxidizing bacteria (AOB) populations in all five reactors stabilized by the fourth month of operation and then did not vary subsequently. Furthermore, a dendrogram generated using the Jaccard distance showed that the AOB in each side-stream reactor was most similar to the main-stream reactor in the same train indicating that the AOB population in the side-stream reactor exerts a strong influence on the population in the main-stream reactor. Sequencing results indicated that Nitrosomonas europea, an r-strategist, was the dominant AOB in the PFR side-stream reactor, while Nitrosomonas europea and Nitrosomonas marina, a marine bacterium, were strongly represented in the CSTR side-stream reactor.
Collapse
Affiliation(s)
- R C Smith
- Department of Civil and Environmental Engineering, University of Cincinnati, Cincinnati, OH 45221, USA.
| | | |
Collapse
|
37
|
Yu JJ, Kirkland TN, Hall LK, Wopschall J, Smith RC, Hung CY, Chen X, Tarcha E, Thomas PW, Cole GT. Characterization of a serodiagnostic complement fixation antigen of Coccidioides posadasii expressed in the nonpathogenic Fungus Uncinocarpus reesii. J Clin Microbiol 2005; 43:5462-9. [PMID: 16272471 PMCID: PMC1287831 DOI: 10.1128/jcm.43.11.5462-5469.2005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Coccidioides spp. (immitis and posadasii) are the causative agents of human coccidioidomycosis. In this study, we developed a novel system to overexpress coccidioidal proteins in a nonpathogenic fungus, Uncinocarpus reesii, which is closely related to Coccidioides. A promoter derived from the heat shock protein gene (HSP60) of Coccidioides posadasii was used to control the transcription of the inserted gene in the constructed coccidioidal protein expression vector (pCE). The chitinase gene (CTS1) of C. posadasii, which encodes the complement fixation antigen, was expressed using this system. The recombinant Cts1 protein (rCts1(Ur)) was induced in pCE-CTS1-transformed U. reesii by elevating the cultivation temperature. The isolated rCts1(Ur) showed chitinolytic activity that was identical to that of the native protein and had serodiagnostic efficacy comparable to those of the commercially available antigens in immunodiffusion-complement fixation tests. Using the purified rCts1(Ur), 74 out of the 77 coccidioidomycosis patients examined (96.1%) were positively identified by enzyme-linked immunosorbent assay. The rCts1(Ur) protein showed higher chitinolytic activity and slightly greater seroreactivity than the bacterially expressed recombinant Cts1. These data suggest that this novel expression system is a useful tool to produce coccidioidal antigens for use as diagnostic antigens.
Collapse
Affiliation(s)
- J-J Yu
- Department of Medical Microbiology and Immunology, Medical College of Ohio, Toledo, Ohio, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Affiliation(s)
- N J Everitt
- Department of Surgery, The Northern General Hospital, Herries Road, Sheffield S5 7AU, UK
| | - S Plusa
- Nutrition Support Team, Clinical Sciences Building, St James's University Hospital, Leeds LS9 7TF UK
| | - S R Kohlhardt
- Sydney University Department of Surgery, Wallace Freeborn Professorial Block, Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia
| | - R C Smith
- Sydney University Department of Surgery, Wallace Freeborn Professorial Block, Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia
| |
Collapse
|
39
|
Abstract
Adult intussusception occurs infrequently and differs from childhood intussusception in its presentation, aetiology, and treatment. Diagnosis can be delayed because of its longstanding, intermittent, and non-specific symptoms and most cases are diagnosed at emergency laparotomy. With more frequent use of computed tomography in the evaluation of patients with abdominal pain, the condition can be diagnosed more reliably. Treatment entails simple bowel resection in most cases. Reduction of the intussusception before resection is controversial, but there is a shift against this, especially in colonic cases. Surgical treatment can be difficult in gastroduodenal and coloanal intussusceptions, sometimes requiring innovative techniques. This paper presents the diagnosis and management of four cases of adult intussusception, followed by review of the literature.
Collapse
Affiliation(s)
- S Yalamarthi
- Department of General Surgery, Falkirk District and Royal Infirmary, Falkirk, Scotland
| | | |
Collapse
|
40
|
Pola R, Gaetani E, Flex A, Aprahamian TR, Bosch-Marcé M, Losordo DW, Smith RC, Pola P. Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors. J Mol Cell Cardiol 2004; 36:363-70. [PMID: 15010275 DOI: 10.1016/j.yjmcc.2003.10.016] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/07/2003] [Revised: 10/13/2003] [Accepted: 10/28/2003] [Indexed: 11/27/2022]
Abstract
OBJECTIVE Until recently, prostacyclin (PGI2) biological activities were thought to be exclusively mediated by cell surface receptors named IP. Recent studies have instead identified a novel pathway of PGI2 signaling, occurring through activation of peroxisome proliferator-activated receptors (PPARs) located in the nucleus. The availability of stable PGI2 analogs with different affinity for IP receptors and PPARs provides the possibility to test the importance and function of this dual pathway in vitro and in vivo. In this study, the in vivo angiogenic properties of different PGI2 analogs and the potential relationship between PPAR-mediated pathways, vascular endothelial growth factor (VEGF), and angiogenesis were investigated. METHODS AND RESULTS By using the murine corneal model of angiogenesis, we found that PGI2 analogs able to act on nuclear PPARs, such as iloprost and carbaprostacyclin (cPGI), induce angiogenesis in vivo. In contrast, cicaprost, a PGI2 analog that only acts on IP receptors, has no in vivo angiogenic activity. Interestingly, angiogenesis induced by iloprost and cPGI does not differ in extent and morphology from that induced by VEGF and is associated with local increment of VEGF mRNA expression and protein levels. Finally, iloprost-induced angiogenesis is significantly decreased by systemic inhibition of VEGF activity, obtained by gene transfer of a soluble form of the VEGF receptor Flt-1. CONCLUSIONS These data demonstrate that stable PGI2 analogs may have angiogenic properties in vivo, depending on their ability to act on PPARs. The resulting angiogenic process appears to be mediated by VEGF. These findings indicate that important physiological activities in the cardiovascular system, such as angiogenesis and VEGF induction, may be modulated by PGI2 through specific activation of the PPAR signaling pathway in vivo, with potentially important fundamental and clinical implications.
Collapse
Affiliation(s)
- R Pola
- Laboratory of Vascular Biology and Genetics, Istituto di Patologia Speciale Medica, A Gemelli University Hospital, Largo A Gemelli 8, Rome 00168, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Takahashi A, Palmer-Opolski M, Smith RC, Walsh K. Transgene delivery of plasmid DNA to smooth muscle cells and macrophages from a biostable polymer-coated stent. Gene Ther 2003; 10:1471-8. [PMID: 12900762 DOI: 10.1038/sj.gt.3302010] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Metallic stents coated with a polyurethane emulsion containing plasmid DNA were implanted in rabbit iliac arteries to evaluate transgene delivery and expression in the vessel wall. The expression of the plasmid-encoded marker genes, beta-galactosidase, luciferase and green fluorescence protein (GFP), were evaluated at 7 days after implantation. In all cases, plasmid transfer was confined to the vessel wall at the site of stent implantation, plasmid DNA was not observed in vessel segments immediately proximal or distal to the stent and dissemination of plasmid DNA to lung, liver or spleen was not observed. Expression of transgenes occurred only in vessel segments in contact with the stent and analysis of the GFP expression pattern revealed a high frequency of marker protein-positive cells occurring at or near the luminal surface. The extent of transgene expression was dependent upon the quantity of DNA loaded onto the stent and no signal was detected in vessel segments that received polymer-coated stents lacking plasmid DNA. Of significance, colocalization studies identified transgene expression not only in vascular smooth muscle cells but also in macrophages. Hence, polymer-coated stents provide a new capability for transgene delivery to immune cells that are believed to contribute to the development of in-stent restenosis.
Collapse
Affiliation(s)
- A Takahashi
- Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA, USA
| | | | | | | |
Collapse
|
42
|
|
43
|
|
44
|
|
45
|
Kingsley K, Rust WL, Huff JL, Smith RC, Plopper GE. PDGF-BB enhances expression of, and reduces adhesion to, laminin-5 in vascular smooth muscle cells. Biochem Biophys Res Commun 2002; 294:1017-22. [PMID: 12074578 DOI: 10.1016/s0006-291x(02)00592-2] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The laminin family of extracellular matrix (ECM) proteins plays crucial roles in regulating cellular growth, migration, and differentiation. We report here that laminin-5 is expressed in the tunica media of the rat aorta and pulmonary arteries. Using indirect immunofluorescence microscopy, Western blots, and RT-PCR analysis, we found that primary cultures of rat arterial smooth muscle cells express laminin-5 and deposit it into their insoluble ECM. These cells also attach strongly to laminin-5 via beta1 integrin receptors in 30 min adhesion assays. Laminin-5 expression in these cells is upregulated by growth factors in vitro and platelet-derived growth factor (PDGF-BB) stimulation reduces adhesion to laminin-5. As laminin-5 promotes enhanced migration of other cell types, the production of and adhesion to laminin-5 by vascular smooth muscle cells may play a role in the pathological growth and migration of these cells associated with restenosis following vascular injury.
Collapse
Affiliation(s)
- K Kingsley
- Department of Biological Sciences, University of Nevada, Las Vegas, NV, USA
| | | | | | | | | |
Collapse
|
46
|
|
47
|
|
48
|
|
49
|
|
50
|
|